ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $633,000 | +4.5% | 26,140 | +0.7% | 0.12% | -36.6% |
| Q4 2021 | $606,000 | +13.9% | 25,957 | -19.0% | 0.18% | -39.8% |
| Q3 2021 | $532,000 | -20.2% | 32,030 | +17.0% | 0.30% | +93.6% |
| Q2 2021 | $667,000 | -6.2% | 27,365 | -0.7% | 0.16% | -28.6% |
| Q1 2021 | $711,000 | -55.0% | 27,565 | -6.7% | 0.22% | -52.4% |
| Q4 2020 | $1,580,000 | +29.0% | 29,555 | -0.5% | 0.46% | +43.9% |
| Q3 2020 | $1,225,000 | -23.3% | 29,700 | -9.9% | 0.32% | -31.0% |
| Q2 2020 | $1,598,000 | +20.4% | 32,970 | +0.5% | 0.46% | +8.6% |
| Q1 2020 | $1,327,000 | -8.1% | 32,810 | -2.8% | 0.43% | +28.9% |
| Q4 2019 | $1,444,000 | – | 33,755 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |